<DOC>
	<DOCNO>NCT00331435</DOCNO>
	<brief_summary>The purpose study evaluate conduct exploratory comparison efficacy safety indocyanine green angiography ( ICGA ) guide photodynamic therapy ( PDT ) fluorescein angiography ( FA ) guide PDT exudative age-related macular degeneration ( AMD ) accompany polypoidal choroidal vasculopathy ( PCV ) .</brief_summary>
	<brief_title>PDT Study Exudative AMD With PCV</brief_title>
	<detailed_description>PDT verteporfin proven beneficial patient AMD . The laser spot size decide base FA find ( FA guide PDT ) . ICGA need detect PCV lesion , polypoidal lesion abnormal network vessel . In clinical practice , PDT base ICGA ( ICGA guide PDT ) conduct treatment AMD PCV . However , report outcomes prospective research PDT PCV Japanese patient . Furthermore , report compare FA guide PDT ICGA guide PDT . We propose conduct clinical research order investigate efficacy safety PDT PCV Japanese patient , compare result FA guide PDT ICGA guide PDT .</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Verteporfin</mesh_term>
	<criteria>Japanese patient age 50 year old old Exudative AMD subfoveal PCV Eyes PCV meet definite criterion PCV issue Japanese study group Polypoidal Choroidal Vasculopathy PCV lesion subfoveal hemorrhage exudation Lesion size ( GLD ) less 12 MPS Disc area measure FA IA . Decimal BCVA 0.10.5 baseline period . Patients RPE tear , vitelliform retinal dystrophy , central Serous Chorioretinopathy . Patients ocular disease irreversible VA Study eye unable take fundus photo CNV Study eye receive surgery operation within 2 month participation study ND : YAG operation within one month Pathological myopia PCV cleary identify subsensory retinal CNV ( RPE ) baseline examination Study eye receive treatment CNV , PDT , transpupillary thermotherapy , laser photocoagulation , . Patients physical problem use angiography PDT ( systemic debility , significant diabetes mellitus , significant heart disease , ) Medical history porphyria , porphyrin sensitivity , hypersensitivity sunlight bright light . Patients medical history hypersensitivity ingredient Visudyne Patients medical history hypersensitivity ingredient fluorescein indocyanine green injection Patients hypersensitivity iodine Patients judge inappropriate study investigator</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>AMD</keyword>
	<keyword>PCV</keyword>
	<keyword>PDT</keyword>
</DOC>